Dem senators ask drug companies to list prices in ads

Dem senators ask drug companies to list prices in ads

A group of mostly Democratic senators is urging eight major drug companies to include the price of their drugs in advertisements, a measure that President TrumpDonald John TrumpTrump mocks wind power: 'When the wind doesn't blow, just turn off the television' Pentagon investigator probing whether acting chief boosted former employer Boeing Trump blasts McCain, bemoans not getting 'thank you' for funeral MORE endorsed last week in his drug-pricing blueprint.

“We are pleased that the President recently acknowledged the importance of requiring price disclosure on direct-to-consumer ads—it is our hope that he will actually follow through,” Sens. Dick DurbinRichard (Dick) Joseph DurbinSenate Dems petition Saudi king to release dissidents, US citizen GOP moves to rein in president's emergency powers Senate votes to confirm Neomi Rao to appeals court MORE (D-Ill.), Kirsten GillibrandKirsten Elizabeth GillibrandGillibrand shows off 'just trying to get some ranch' t-shirt Rubio to introduce legislation to keep Supreme Court at 9 seats The Hill's Morning Report - Trump, Dems put manufacturing sector in 2020 spotlight MORE (D-N.Y.), Maggie HassanMargaret (Maggie) HassanOvernight Health Care: Survey finds 1 in 10 ration medicines to lower costs | Senate Dems call for hearing on Trump abortion rule | Trump health chief backs needle exchanges | Outgoing FDA chief keeps heat on e-cig maker Lawmakers introduce bipartisan bill for 'internet of things' security standards Koch-backed group pushes for new limits on Trump's tariff authority MORE (D-N.H.), Sherrod BrownSherrod Campbell BrownWarren, Klobuchar call on FTC to curtail use of non-compete clauses The Hill's Morning Report - Trump, Dems put manufacturing sector in 2020 spotlight Trump faces political risks in fight over GM plant MORE (D-Ohio) and Angus KingAngus Stanley KingOvernight Defense: Senate rejects border emergency in rebuke to Trump | Acting Pentagon chief grilled on wall funding | Warren confronts chief over war fund budget Shanahan grilled on Pentagon's border wall funding Senators offer bipartisan bill to fix 'retail glitch' in GOP tax law MORE (I-Maine) wrote to the drug companies.

“As an honest first step to the American public, we urge you to immediately and voluntarily commit to transparency and disclose the price of your prescription drugs in direct-to-consumer advertisements,” the letter sent Friday states.

ADVERTISEMENT

The letter was sent to major pharmaceutical companies such as Eli Lilly, Novartis and Pfizer. 

Trump released a plan last week directing the Food and Drug Administration to study the possibility of including the list prices of drugs in direct-to-consumer advertising. The measure was part of Trump's blueprint aimed at lowering prescription drug costs.

Durbin introduced a bill last year that would require a similar disclosure of drug prices.

While pharmaceutical companies have to include warnings and side effects for drugs in television advertisements, they currently do not have to include prices.

Some have voiced concerns that including the list price of drugs could confuse consumers or deter them from purchasing the product, since the price at a pharmacy is often much lower if the individual has health insurance.

At an event with reporters Tuesday, Lori Reilly, an executive vice president of the Pharmaceutical Research and Manufacturers of America (PhRMA), discussed the issue of forcing companies to include the price of drugs in ads, arguing "it’s an open question about whether or not it’s constitutional.”

This post was updated at 4 p.m.